PSTV
$2.18
Plus Therapeutics
$.04
1.87%
PSTV
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.22)
Revenue:  N/A
Thursday
Oct 21
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PSTV reports earnings?
Beat
Meet
Miss

Where is PSTV's stock price going from here?
Up
Flat
Down
Stock chart of PSTV
Analysts
Summary of analysts' recommendations for PSTV
Score
Grade
Pivots
Resistance
$2.41
$2.33
$2.24

$2.15

Support
$2.06
$1.98
$1.88
Tweet
Growth
Description
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.